The Journal of Clinical PharmacologyPharmacology & ToxicologyPeer-reviewed journal article
Partial Differential Equation (PDE) Based Spatial Pharmacometrics in NONMEM: Method of Lines (MOL) Implementation With AI-Assisted Model Development
Abstract
Spatial heterogeneity in drug distribution, particularly within solid tumors, can compromise target engagement and drive therapeutic failure in oncology, yet it is rarely represented in population pharmacokinetic (PopPK) analyses. Standard empirical compartmental or semi-mechanistic models assume "well-stirred" tissues, and physiologically based pharmacokinetic (PBPK) models focus on organ-level distribution; neither framework directly captures intra-tumoral drug concentration gradients. Reaction-diffusion PDEs provide a mechanistic representation of penetration, spatial gradients, and washout, but routine implementation in NONMEM has been limited by operational complexity in the pharmacometrics field: native numerical templates (e.g., DOPDE/DOEXPAND-style expansions offered by NONMEM) remain cumbersome, and manual MOL coding quickly becomes labor-intensive and error-prone as geometry, initial and boundary conditions, and grid resolution change. With the emergence of advanced AI technologies, this operational barrier can be substantially reduced. This work presents a streamlined workflow for implementing spatial PDEs in NONMEM via AI tools. Using AI-assisted explicit code generation, we show how continuous spatial models can be systematically translated into coupled ordinary differential equation (ODE) systems that are directly executable in NONMEM, while keeping the resulting $DES block implementation transparent and reviewable. We illustrate the approach with one-dimensional, spherical, and two-dimensional rectangular reaction-diffusion models and provide practical guidance for iterative refinement across discretization and boundary-condition settings using appropriate prompt engineering with AI. Although AI does not reduce stiffness, remove numerical constraints, or resolve identifiability limitations, it reduces the engineering and maintenance burden of large MOL systems. When coupled with disciplined verification and appropriate scientific restraint, AI-assisted code generation can make PDE-based spatial pharmacometrics in NONMEM practical, transparent, and maintainable--supporting wider adoption of spatial modeling to interrogate target-site exposure and penetration-driven efficacy.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 32th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Stochastic Differential Equations (SDEs) in NONMEM for Probing Population Pharmacokinetic Model Misspecification: Diagnostic Utility, Practical Considerations, and Future Directions
Ping Chen, Robert J. Bauer, Yan Li·The AAPS JournalPeer-reviewed·Sep 4, 2026
- Physiologically Based Multiphysics Pharmacokinetic Model for Determining the Temporal Biodistribution of Targeted Nanoparticles
e. glass, S. Kulkarni, … R. Radhakrishnan·bioRxiv·Mar 7, 2022
- Generic Purpose Pharmacokinetics-Pharmacodynamics Mathematical Model For Nanomedicine Targeted Drug Delivery: Mouse Model
Teddy Lazebnik, Hanna Weitman, Gal A. Kaminka·bioRxiv·Jul 13, 2022
- DiffDose: Differentiable Programming for Personalized Dose-Regimen Optimal Control
Shayan Hajhashemi, Amin Emad, Morgan Craig·bioRxiv·Sep 13, 2026
- Accelerated Predictive Healthcare Analytics with Pumas, A High Performance Pharmaceutical Modeling and Simulation Platform
C. V. Rackauckas, Y. Ma, … V. Ivaturi·bioRxiv·Nov 28, 2020
- A spatially resolved mechanistic growth law for cancer drug development.